Clinical use of the Onclarity test with extended HPV genotyping and phenotyping in patients with suspected squamous intraepithelial lesions.

Dominik Pruski Marcin PrzybylskiPaula KlemenskaJoanna Figula Marcin Przybylski

Published in: Ginekologia polska (2023)

The Onclarity test is characterised by high sensitivity and specificity in detecting CIN2+ lesions. Extended genotyping enables the identification of the most common oncogenic HPV types in the population. It can be used as a basic tool for secondary prevention or together with LBC.

Keyphrases

high grade
high throughput
low grade
genome wide
genetic diversity
transcription factor
gene expression
bioinformatics analysis
cervical cancer screening